H-cadherin is a newly characterized cadherin molecule whose expression is decreased in a variety of human carcinoma cells, suggesting that it may play a role in maintaining normal cellular phenotype. To investigate how re-expression of H-cadherin could influence the malignant phenotype of human breast carcinoma cells in vivo, we transfected both control and H-cadherin expression vectors into human breast cancer cells (MDAMB435), which do not express H-cadherin constitutively. We found that invasiveness of these cells could be prevented by transfection with H-cadherin. We also compared the ability of controland H-cadherin-transfected cells to induce subcutaneous tumors after injection into mammary fat pads of nude mice. Our results show that H-cadherin transfection produced a marked inhibition of tumor growth and modified the morphology of tumor cells: tumors from mice injected with control cells were significantly larger and contained larger cells having a higher degree of pleomorphism than those of tumors generated from carcinoma cells expressing H-cadherin. Altogether, these results indicate that Hcadherin expression antagonizes tumor growth in nude mice, presumably by enhancing cell-cell association in a tissue environment. These findings strongly suggest that H-cadherin could provide a possible target for corrective gene therapy against breast cancer.
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Cadherins are members of a large family of transmembrane glycoproteins that mediate calcium-dependent, homophilic, and to a lesser extent heterophilic, cell-cell adhesion, and play an important role in the maintenance of normal tissue architecture (1) (2) (3) (4) . It is now clear that cadherins are involved in tumor cell-cell adhesion, and that cadherin dysfunction is implicated in tumor development (1) (2) (3) (4) . Cell-cell association is often disorganized in human tumors and is thought to be a cause of the unregulated behavior of tumor cells, including invasion and metastasis (5) (6) (7) (8) contribute to the tumorigenic phenotype, implicating cadherins as putative products of tumor suppressor genes (9-11). H-cadherin, a new member of the cadherin family of cell adhesion molecules, was recently isolated and found to have a lower expression profile in carcinoma cells (8). The Hcadherin gene has been mapped to chromosome 16q24. Extensive breast cancer allelotypic studies have systematically shown the common occurrence of allelic losses affecting chromosome 16q (12) (13) (14) (15) (16) (17) . In particular, two regions of 16q are consistently lost: 16q21 or 16q24.2-ter, suggesting that a candidate tumor suppressor gene or genes localized in these regions could play an important role in breast cancer development (15) (16) (17) .
H-cadherin was previously analyzed with respect to a role in breast tumor cell growth. We demonstrated that H-cadherin overexpression, after transfection into breast cancer cell lines, produced significant growth inhibition in vitro (8). In addition, re-expression of H-cadherin in these cell lines resulted in the recovery of normal cellular phenotypes when placed in the Matrigel outgrowth assay, which provides a three-dimensional matrix environment that mimics the in vivo situation (8).
In the present study, we have investigated whether H-cadherin expression could influence the rate of tumor growth in vivo. An established human breast cancer cell line, MDAMB435, in which endogenous H-cadherin is not detectable, was transfected with the full length H-cadherin cDNA or with the control vector pCDNA3. Stable transfected clones expressing levels of H-cadherin mRNA similar to those expressed by normal breast epithelial cells were selected and used for in vivo studies ( Figure 1 ). As an in vitro measure of invasive capacities, we also examined the abilities of H-cadherin-transfected MDAMB435 cells as compared with control vector-transfected cells to invade and traverse a Matrigel-coated membrane, using fetal bovine serum (FBS) as a chemo-attractant on the opposite side of the membrane. This invasion assay revealed prominent differences between H-cadherin transfectants and the parental or vector-transfected MDAMB435 cells (Figure 2 ). Hcadherin transfectants (MDAMB435-S6, -S21 and -S27) showed 70-80% reduction of invasive ability of MDAMB435 cells at 2 days after seeding onto the matrigel membrane compared with control transfectants (C1 and C8) and parental MDAMB435 cells in the Matrigel invasion assay. This result provides evidence that increased expression of H-cadherin in the human breast cancer MDAMB435 cells can facilitate suppression of tumor cell invasion across a basement membrane-like matrix in vitro, which may be mediated by increased cell-cell interaction.
For in vivo studies, subconfluent cells were trypsinized and resuspended in serum-free Dulbecco's modified Eagle's medium (DMEM). The cells (2ϫ10 6 ) in a volume of 0.2 ml were injected subcutaneously into the mammary fat pads of 6-week-old female athymic Ncr nude mice (Taconic, Germantown, NY) as previously described (18) . Two pCDNA3-control vector-transfected (C1 and C8) and two H-cadherin-transfected MDAMB435 clones (S6 and S27) were used. Six mice were injected with each cloned cell population in two different sites. Tumors were allowed to grow for 4 weeks, harvested and weighed (Table I ). MDAMB435 cells transfected with the pCDNA3 control vector generated large tumors that averaged~170 mg (mean number). In contrast, injection of H-cadherin-transfected MDAMB435 cells generated much smaller tumors that averaged~18 mg, or there were no tumors at all (Figure 3) . The difference between controland H-cadherin-transfected cell tumor wt was of high statistical significance (P Ͻ 0.0001).
The histology of tumors formed by control and H-cadherin transfected MDAMB435 cells were not markedly different, both consistent with that of poorly differentiated carcinomas. However, tumors generated after transfection of the control vector contained wider areas of necrosis, and were composed of larger cells with a higher degree of pleomorphism than those of small tumors generated after transfection of MDAMB435 cells with the H-cadherin gene (Figure 4) .
Carcinogenesis is a multistep process, and many of the events leading to the development of malignancies are either unknown or poorly understood. Invasion and metastasis are genesis. In the present study, we have demonstrated that one new member of the cadherin family, H-cadherin, markedly interfered with tumor growth in an in vivo nude mouse. In addition, we also found that re-expression of H-cadherin can diminish the invasive potentials of human breast cancer cells.
Several lines of evidence presented here suggest that Hcadherin, like other members of the cadherin family, may inhibit tumorigenicity, presumably by maintaining tight intercellular adhesions. Further work is required to elucidate the molecular mechanisms of H-cadherin in normal and tumor cell biology. Our studies suggest that H-cadherin could represent an important target for breast cancer gene therapy.
